Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations - PubMed (original) (raw)
. 2005 Jun 16;24(26):4220-31.
doi: 10.1038/sj.onc.1208597.
Affiliations
- PMID: 15824740
- DOI: 10.1038/sj.onc.1208597
Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations
Xiaomei Zhang et al. Oncogene. 2005.
Abstract
The majority (75%) of human breast cancers express estrogen receptor (ER). Although ER-positive tumors usually respond to antiestrogen therapies, 30% of them do not. It is not known what controls the ER status of breast cancers or their responsiveness to antihormone interventions. In this report, we document that transgenic (TG) expression of Wnt-1 in mice induces ER-positive tumors. Loss of Pten or gain of Ras mutations during the evolution of tumors in Wnt-1 TG mice has no effect on the expression of ER, but overexpression of Neu or loss of p53 leads to ER-negative tumors. Thus, our results provide compelling evidence that expression of ER in breast cancer may be influenced by specific genetic changes that promote cancer progression. These findings constitute a first step to explore the molecular mechanisms leading to ER-positive or ER-negative mammary tumors. In addition, we find that ER-positive tumors arising in Wnt-1 TG mice are refractory to both ovariectomy and the ER antagonist tamoxifen, but lose ER expression with tamoxifen, suggesting that antiestrogen selects for ER-negative tumor cells and that the ER-positive cell fraction is dispensable for growth of these tumors. This is a first report of a mouse model of antiestrogen-resistant ER-positive breast cancers, and could provide a powerful tool to study the molecular mechanisms that control antiestrogen resistance.
Similar articles
- A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS. Bocchinfuso WP, et al. Cancer Res. 1999 Apr 15;59(8):1869-76. Cancer Res. 1999. PMID: 10213494 - Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H, Cui Y, Dupont J, Sun H, Hennighausen L, Yakar S. Zhao H, et al. Cancer Res. 2005 Aug 1;65(15):6864-73. doi: 10.1158/0008-5472.CAN-05-0181. Cancer Res. 2005. PMID: 16061670 - Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF. Nguyen A, et al. Int J Oncol. 2005 Oct;27(4):949-56. Int J Oncol. 2005. PMID: 16142310 - Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H, Arteaga CL. Kurokawa H, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4436s-4442s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916237 Review. - PTEN deficiency: a role in mammary carcinogenesis.
Petrocelli T, Slingerland JM. Petrocelli T, et al. Breast Cancer Res. 2001;3(6):356-60. doi: 10.1186/bcr322. Epub 2001 Oct 1. Breast Cancer Res. 2001. PMID: 11737885 Free PMC article. Review.
Cited by
- Different Oncogenes and Reproductive Histories Shape the Progression of Distinct Premalignant Clones in Multistage Mouse Breast Cancer Models.
Linscott MP, Ren JR, Gestl SA, Gunther EJ. Linscott MP, et al. Am J Pathol. 2024 Jul;194(7):1329-1345. doi: 10.1016/j.ajpath.2024.02.018. Epub 2024 Mar 25. Am J Pathol. 2024. PMID: 38537934 - Functional cooperation between co-amplified genes promotes aggressive phenotypes of HER2-positive breast cancer.
Yang Y, Leonard M, Luo Z, Yeo S, Bick G, Hao M, Cai C, Charif M, Wang J, Guan JL, Lower EE, Zhang X. Yang Y, et al. Cell Rep. 2021 Mar 9;34(10):108822. doi: 10.1016/j.celrep.2021.108822. Cell Rep. 2021. PMID: 33691110 Free PMC article. - Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo.
Bu W, Li Y. Bu W, et al. J Mammary Gland Biol Neoplasia. 2020 Dec;25(4):389-396. doi: 10.1007/s10911-020-09469-w. Epub 2020 Nov 9. J Mammary Gland Biol Neoplasia. 2020. PMID: 33165800 Free PMC article. - Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines.
Smart E, Alejo LH, Frasor J. Smart E, et al. Horm Cancer. 2020 Apr;11(2):76-86. doi: 10.1007/s12672-020-00378-2. Epub 2020 Feb 1. Horm Cancer. 2020. PMID: 32008217 Free PMC article. - CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nie L, Wei Y, Zhang F, Hsu YH, Chan LC, Xia W, Ke B, Zhu C, Deng R, Tang J, Yao J, Chu YY, Zhao X, Han Y, Hou J, Huo L, Ko HW, Lin WC, Yamaguchi H, Hsu JM, Yang Y, Pan DN, Hsu JL, Kleer CG, Davidson NE, Hortobagyi GN, Hung MC. Nie L, et al. Nat Commun. 2019 Nov 8;10(1):5114. doi: 10.1038/s41467-019-13105-5. Nat Commun. 2019. PMID: 31704972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous